Current NDC auxiliary source row compounder:2089

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83826-9080
Product Ndc: 83826-9080
Product Ndc Digits: 838269080
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Moxiflocacin HCl
Proprietary Name Suffix: [empty]
Nonproprietary Name: Moxiflocacin HCl 0.1%
Dosage Form Name: SOLUTION
Route Name: INTRACAMERAL; OPHTHALMIC
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: OSRX, Inc.
Establishment Name: OSRX, Inc.
Establishment Fei: [empty]
Substance Name: MOXIFLOXACIN HYDROCHLORIDE
Active Ingredients Info: 1 mg/1 mL
History Active Ingredients Raw: MOXIFLOXACIN HYDROCHLORIDE
History Active Ingredients Info Raw: 1 mg/1 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 83826-9080-1
Package Ndc: 83826-9080-1
Package Ndc Digits: 8382690801
Package Ndc11: 83826908001
Package Description: 1 mL in 1 VIAL (83826-9080-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2089
Source Row Number: 2089
Source Row Hash: 13c02c44cd4eb83daccf68781789504be37d89aaa5d050044bd5c59fcab42d0e
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACAMERAL; OPHTHALMIC",
    "PRODUCTNDC": "83826-9080",
    "DEASCHEDULE": "",
    "LABELERNAME": "OSRX, Inc.",
    "SUBSTANCENAME": "MOXIFLOXACIN HYDROCHLORIDE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "83826-9080-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Moxiflocacin HCl",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Moxiflocacin HCl 0.1%",
    "PACKAGEDESCRIPTION": "1 mL in 1 VIAL (83826-9080-1) ",
    "ACTIVEINGREDIENTSINFO": "1 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2089
Source Row Number: 2089
Status Scope: package
Lookup Ndc: 83826-9080-1
Lookup Ndc Digits: 8382690801
Product Ndc: 83826-9080
Product Ndc Digits: 838269080
Package Ndc: 83826-9080-1
Package Ndc Digits: 8382690801
Package Ndc11: 83826908001
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 13c02c44cd4eb83daccf68781789504be37d89aaa5d050044bd5c59fcab42d0e
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01